Physician profile
Hillary Brass
NPI 1023484839
$528.43
in general payments reported to CMS, 2019-2025
14 companies · $45.85 in 2025
The $45.85 reported for 2025 was less than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.30 · 2022: $159 · 2023: $159 · 2024: $109 · 2025: $45.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.38 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $140.46 | 2023-2024 | Veozah |
| Myovant Sciences INC. | $80.46 | 2022 | |
| Organon LLC | $66.77 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $45.30 | 2024-2025 | Myfembree |
| Coopersurgical, INC. | $44.24 | 2022-2024 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $29.56 | 2021-2023 | |
| Abbvie INC. | $24.29 | 2023 | |
| Evofem Biosciences, INC. | $15.95 | 2022 | |
| Millicent US INC | $15.82 | 2024 | Intrarosa, Femring |
| Seqirus USA INC | $14.32 | 2025 | Fluad, Flucelvax |
| Pfizer INC. | $13.87 | 2025 | |
| Therapeuticsmd, INC. | $13.40 | 2021 | |
| Agile Therapeutics, INC. | $12.18 | 2021 | |
| Shield Therapeutics INC | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Brass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.